{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:35:53Z","timestamp":1767980153527,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1053\/j.jvca.2023.09.041","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T07:21:44Z","timestamp":1698391304000},"page":"275-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recombinant Activated Factor VII (rFVIIa) for Bleeding After Thoracic Aortic Surgery: A Scoping Review of Current Literature"],"prefix":"10.1053","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8407-4108","authenticated-orcid":false,"given":"Ryan","family":"Navarro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Bojic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubab","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"El-Tahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1807-8397","authenticated-orcid":false,"given":"Mohammad","family":"El-Diasty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2023.09.041_bib0001","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2516.2007.01601.x","article-title":"Single 270\u03bcgkg-1 -dose RFVIIa vs. standard 90\u03bcgkg-1 -dose RFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: A randomized comparison","volume":"14","author":"Young","year":"2008","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2023.09.041_bib0002","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2006-04-017988","article-title":"A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: The FEIBA NovoSeven comparative (FENOC) study","volume":"109","author":"Astermark","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2023.09.041_bib0003","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsha.2016.03.001","article-title":"Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery","volume":"28","author":"Habib","year":"2016","journal-title":"J Saudi Heart Assoc"},{"key":"10.1053\/j.jvca.2023.09.041_bib0004","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.jvca.2011.03.004","article-title":"Recombinant activated factor VII increases stroke in cardiac surgery: A meta-analysis","volume":"25","author":"Ponschab","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2001-16890","article-title":"SE Bj\u00f8rn, Recombinant activated factor VII (RFVIIa): characterization, manufacturing, and clinical development","volume":"27","author":"Jurlander","year":"2001","journal-title":"Semin Thromb Hemost"},{"key":"10.1053\/j.jvca.2023.09.041_bib0006","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-154-8-201104190-00002","article-title":"Off-label use of recombinant factor VIIa in U.S. hospitals: Analysis of hospital records","volume":"154","author":"Logan","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jvca.2023.09.041_bib0007","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13019-014-0156-y","article-title":"Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type A dissection operations","volume":"9","author":"Yan","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.108.834275","article-title":"Safety and efficacy of recombinant activated factor VII: A randomized placebo-controlled trial in the setting of bleeding after cardiac surgery","volume":"120","author":"Gill","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2023.09.041_bib0009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/ALN.0000000000004569","article-title":"Off-label use of recombinant activated factor VII for cardiac surgical bleeding","volume":"139","author":"Flynn","year":"2023","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2023.09.041_bib0010","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/01.CCM.0000269033.89428.B3","article-title":"Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: A propensity score analysis","volume":"35","author":"Tritapepe","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2023.09.041_bib0011","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jtcvs.2012.01.004","article-title":"Intraoperative use of recombinant activated factor VII during complex aortic surgery","volume":"143","author":"Goksedef","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0012","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejcts.2007.10.004","article-title":"Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): A propensity score analysis","volume":"33","author":"Gelsomino","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0013","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1590\/S0103-507X2011000300008","article-title":"Postoperative complications of surgically treated ascending aortic dissection","volume":"23","author":"Almeida","year":"2011","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1053\/j.jvca.2023.09.041_bib0014","first-page":"498","article-title":"Predictors and impact of massive bleeding in acute type A aortic dissection","volume":"24","author":"Zindovic","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/ejcts\/ezy469","article-title":"Preoperative dual antiplatelet therapy increases bleeding and transfusions but not mortality in acute aortic dissection type A repair","volume":"56","author":"Hansson","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0016","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jtcvs.2013.08.008","article-title":"Salvage periaortic pericardial baffle equalizes mortality in bleeding patients undergoing aortic surgery","volume":"148","author":"Toole","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0017","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jth.15195","article-title":"Managing the coagulopathy associated with cardiopulmonary bypass","volume":"19","author":"Bartoszko","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2023.09.041_bib0018","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/TCRM.S352609","article-title":"Recombinant activated factor VII in aortic surgery for patients under hypothermic circulatory arrest","volume":"18","author":"Ise","year":"2022","journal-title":"Ther Clin Risk Manag"},{"key":"10.1053\/j.jvca.2023.09.041_bib0019","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ejcts\/ezx325","volume":"53","author":"Pagano","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0020","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1053\/j.jvca.2019.04.003","article-title":"Society of Cardiovascular Anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients","volume":"33","author":"Raphael","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0885066620984443","article-title":"A comparison of prothrombin complex concentrate and recombinant activated factor VII for the management of bleeding with cardiac surgery","volume":"37","author":"Katz","year":"2022","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2023.09.041_bib0022","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2146\/ajhp060398","article-title":"Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery","volume":"64","author":"Johnson","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1053\/j.jvca.2023.09.041_bib0023","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.jvca.2006.05.017","article-title":"Case 5-2006 recombinant factor VIIa in the management of postoperative bleeding after repair for inadvertently thrombolysed acute type A aortic dissection","volume":"20","author":"Faber","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0024","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2023.09.041_bib0025","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0026","doi-asserted-by":"crossref","unstructured":"JBI Manual for Evidence Synthesis; JBI, 2020. Available at: https:\/\/doi.org\/10.46658\/JBIMES-20-01. Accessed June, 2023.","DOI":"10.46658\/JBIMES-20-01"},{"key":"10.1053\/j.jvca.2023.09.041_bib0027","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jvca.2023.09.041_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2017.08.020","article-title":"Recombinant factor VIIa use in acute type A aortic dissection repair: A multicenter propensity-score-matched report from the nordic consortium for acute type A aortic dissection","volume":"154","author":"Zindovic","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0029","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1111\/jocs.16048","article-title":"Recombinant activated factor VII for hemostasis in patients undergoing complex ascending aortic surgery: A single-center, single-surgeon retrospective analysis","volume":"36","author":"Hang","year":"2021","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.athoracsur.2005.09.003","article-title":"Recombinant activated factor VII: Treating postoperative hemorrhage in cardiac surgery","volume":"81","author":"Bishop","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0031","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.athoracsur.2005.02.044","article-title":"Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery","volume":"80","author":"Raivio","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0032","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.athoracsur.2012.02.037","article-title":"Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations","volume":"93","author":"Andersen","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0033","doi-asserted-by":"crossref","first-page":"6","DOI":"10.35810\/ects.v3i1.171","article-title":"Recombinant factor VIIa for the management of uncontrollable bleeding following the repair of acute type A aortic dissection","volume":"3","author":"Elnaggar","year":"2021","journal-title":"Egypt Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0034","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/ALN.0000000000002179","article-title":"Comparison of two major perioperative bleeding scores for cardiac surgery trials","volume":"129","author":"Bartoszko","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2023.09.041_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2013.10.070","article-title":"Universal definition of perioperative bleeding in adult cardiac surgery","volume":"147","author":"Dyke","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0036","article-title":"Massive bleeding after surgical repair in acute type A aortic dissection patients: Risk factors, outcomes, and the predicting model","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1053\/j.jvca.2023.09.041_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2021.02.096","article-title":"The use of blood and blood products in aortic surgery is associated with adverse outcomes","volume":"165","author":"Sultan","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0038","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1213\/00000539-199710000-00011","article-title":"The systemic inflammatory response to cardiopulmonary bypass","volume":"85","author":"Hall","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0039","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1053\/j.jvca.2017.04.014","article-title":"Hemodilution on cardiopulmonary bypass: Thromboelastography patterns and coagulation-related outcomes","volume":"31","author":"Ranucci","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2516.2005.01075.x","article-title":"Dose effect and efficacy of RFVIIa in the treatment of haemophilia patients with inhibitors: Analysis from the Hemophilia and Thrombosis Research Society Registry","volume":"11","author":"Parameswaran","year":"2005","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2023.09.041_bib0041","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.jvca.2008.08.003","article-title":"Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: A retrospective analysis of dosing, efficacy, and safety outcomes","volume":"23","author":"Masud","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0042","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1076029616651146","article-title":"A snapshot of coagulopathy after cardiopulmonary bypass","volume":"22","author":"H\u00f6fer","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1053\/j.jvca.2023.09.041_bib0043","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/CIRCULATIONAHA.116.023956","article-title":"Point-of-care hemostatic testing in cardiac surgery","volume":"134","author":"Karkouti","year":"2016","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2023.09.041_bib0044","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ajcp\/aqz074","article-title":"The utility of thromboelastography to guide blood product transfusion","volume":"152","author":"Schmidt","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.jvca.2023.09.041_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.thromres.2019.03.022","article-title":"Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients","volume":"178","author":"Schmidt","year":"2019","journal-title":"Thromb Res"},{"key":"10.1053\/j.jvca.2023.09.041_bib0046","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/icvts\/ivs087","article-title":"Re-exploration for bleeding or tamponade after cardiac operation","volume":"14","author":"\u010can\u00e1dyov\u00e1","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0047","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.jvca.2008.09.017","article-title":"Recombinant activated factor VII in cardiac surgery: A meta-analysis","volume":"23","author":"Zangrillo","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0048","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1177\/0310057X1003800409","article-title":"The safety of recombinant factor VIIa in cardiac surgery","volume":"38","author":"Mitra","year":"2010","journal-title":"Anaesth Intensive Care"},{"key":"10.1053\/j.jvca.2023.09.041_bib0049","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.athoracsur.2014.04.126","article-title":"Recombinant factor VII is associated with worse survival in complex cardiac surgical patients","volume":"98","author":"Alfirevic","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ejcts.2005.05.016","article-title":"Multivariate analysis of predictors of late stroke after total aortic arch repair","volume":"28","author":"Matsuura","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2023.09.041_bib0051","article-title":"Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with aortic aneurysms: A nationwide cohort study","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.jvca.2023.09.041_bib0052","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/bja\/aei244","article-title":"Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebo-controlled pilot study","volume":"95","author":"Diprose","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0053","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1537-2995.2005.04216.x","article-title":"Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis","volume":"45","author":"Karkouti","year":"2005","journal-title":"Transfusion (Paris)"},{"key":"10.1053\/j.jvca.2023.09.041_bib0054","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1053\/j.jvca.2011.10.009","article-title":"Possible anaphylaxis due to recombinant factor VIIa administration during thoracic aortic surgery","volume":"26","author":"Wyckoff","year":"2012","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/bja\/aex205","article-title":"The ACTA PORT-Score for predicting perioperative risk of blood transfusion for adult cardiac surgery","volume":"119","author":"Klein","year":"2017","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2023.09.041_bib0056","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.jvca.2014.08.002","article-title":"Prediction of bleeding after cardiac surgery: Comparison of model performances: A prospective observational study","volume":"29","author":"Greiff","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077023008078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077023008078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:05:15Z","timestamp":1760947515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077023008078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1053077023008078"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2023.09.041","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant Activated Factor VII (rFVIIa) for Bleeding After Thoracic Aortic Surgery: A Scoping Review of Current Literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2023.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}